Suchergebnisse - "Wang, Xiaonan"

PubPharm (15)

1

FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway

enthalten in: Journal of translational medicine | 2023

von Chen, E. | Huang, J. | Chen, M. | +12

2

Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation

enthalten in: Cancer research and treatment | 2022

von Wei, Y. | Wei, C. | Chen, L. | +11

3

Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer

enthalten in: International journal of radiation oncology, biology, physics | 2022

von Li, L. | Tang, S. | Yin, J. | +20

4

Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression

enthalten in: Nature genetics | 2021

von Yun, H. | Narayan, N. | Vohra, S. | +19

5

Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma

enthalten in: Nature communications | 2020

von Wang, S. | Du, M. | Zhang, J. | +14

6

Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib

enthalten in: Cancer letters | 2020

von Ding, J. | Yao, Y. | Huang, G. | +11

7

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation

enthalten in: Oncogene | 2020

von Jin, Y. | Bao, H. | Le, X. | +25

ErratumIn: Oncogene. 2019 Dec 12;:. - PMID 31831835

8

Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC

enthalten in: International journal of cancer | 2019

von Wang, J. | Li, X. | Xue, X. | +8

9

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Yang, Z. | Yang, N. | Ou, Q. | +10

10

Acquired EGFR L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Liu, Y. | Li, Y. | Ou, Q. | +4